Decoding Psoriatic Arthritis: Applying Evidence-Based Guidelines for Individualized and Effective Treatment

This activity is part of a series


Amanda Mixon, PA-C
President of Rheumatology Advanced Practice Providers (RhAPP)

Statement of Need

Psoriatic arthritis (PsA) diagnosis and management have been directed by three main sets of guidelines: the American College of Rheumatology (ACR) guidelines, the European Alliance of Associations for Rheumatology (EULAR) guidelines, and the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA) guidelines; GRAPPA represents the most recent data, updated in 2022. New guidelines present a “domain-based approach” to therapy, in which PsA as a disease is subdivided into six domains (peripheral arthritis, axial disease, enthesitis, dactylitis, skin psoriasis [PsO], and nail PsO), and disease activity is individually assessed within each. Other guidelines, namely the 2018 ACR/National Psoriasis Foundation (NPF) guidelines, favor a treat-to-target (T2T) therapy approach that centers remission or low disease activity as a goal with specific disease management targets. Many clinicians delivering PsA care are unfamiliar with these varied guidelines, however, particularly nurse practitioners (NPs) and physician associates (PAs). It is imperative that clinicians collaborating with a multidisciplinary care team are appraised on these guideline-based management strategies to implement them competently in patients with PsA.

In the second activity of this CME Outfitters BriefCase series, expert faculty use case-based learning to demonstrate for learners how best to utilize guideline-based management strategies for patients with PsA.

Learning Objectives

At the conclusion of this activity, learners will be able to better:

  • Utilize guideline-based management strategies for patients with PsA

Financial Support

This activity is supported by an educational grant from Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.- both are Johnson & Johnson companies.

Target Audience

Physicians, nurse practitioners (NPs), and physician associates (PAs) specializing in dermatology and rheumatology

Credit Information

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Interprofessional (IPCE) 0.75

This activity was planned by and for the healthcare team, and learners will receive 0.75 Interprofessional Continuing Education Credit for learning and change.

Physicians (ACCME) 0.75

CME Outfitters, LLC, designates this Enduring Material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses (ANCC) 0.75

This activity is designated for 0.75 contact hours.

California Residents: This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters LLC’s provider number is CEP15510.

Note to Nurse Practitioners: The content of this CNE activity pertains to Pharmacology.

PAs (AAPA) 0.75

CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.75 AAPA Category 1 CME credits. Approval is valid until 02/28/25. PAs should only claim credit commensurate with the extent of their participation.


Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.75 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Disclosure Declaration

Ms. Mixon reports the following financial relationships:

Advisory Board: AstraZeneca; Janssen Pharmaceuticals, Inc.; and Sanofi

Speakers Bureau: AbbVie Inc.; Lilly; and Janssen Pharmaceuticals, Inc.

The following individuals have no financial relationships to disclose: 

Amanda K. Smith, PA-C (Peer Reviewer)
Keshia Pitt, PhD (Planning Committee)
John Jones, PharmD (Planning Committee)
Sandra Caballero, PharmD (Planning Committee)
Sharon Tordoff (Planning Committee)

Obtaining Credit

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (70% pass rate required). This website supports all browsers except Internet Explorer for Mac.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).


Decoding Psoriatic Arthritis: Applying Evidence-Based Guidelines for Individualized and Effective Treatment
Event Date: 02/28/2024